Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 5, 2011, Pages 891-896

  De Almeida, Sérgio Monteiro ^a,b   Boritza, Kátia ^a   Cogo, Laura Lucia ^a   Pessa, Luis ^a   França, João ^a   Rota, Indianara ^a,b   Muro, Marisol ^a   Ribeiro, Cléa ^c   Raboni, Sonia Mara ^a,c   Vidal, Luine Rosele ^a   Nogueira, Meri Bordignon ^a   Ellis, Ronald ^c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

central nervous system; cerebrospinal fluid; chronic meningitis; Cryptococcus neoformans; HIV; lactic acid; lymphocytic meningitis; tuberculosis; viral meningitis

Indexed keywords

GLUCOSE; LACTIC ACID; PROTEIN;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CRYPTOCOCCOSIS; DIFFERENTIAL DIAGNOSIS; ENTEROVIRUS INFECTION; FEMALE; FUNGAL MENINGITIS; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; MYCOBACTERIUM TUBERCULOSIS; NEUROSYPHILIS; NONHUMAN; OPPORTUNISTIC INFECTION; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TOXOPLASMOSIS; TUBERCULOUS MENINGITIS; VIRUS MENINGITIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV INFECTIONS; HUMANS; LACTIC ACID; MALE; MENINGITIS, VIRAL; MIDDLE AGED; YOUNG ADULT;

ENTEROVIRUS; FILOBASIDIELLA NEOFORMANS; HERPESVIRIDAE;

EID: 79954472578     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.131     Document Type: Article

References (40)

1. Hollander H, McGuire D, Burack JH. Diagnostic lumbar punc-ture in HIV-infected patients: analysis of 138 cases. Am J Med 1994;96:223-8. (Pubitemid 24099220)
2. Livramento JA, Machado LR, Spina-Franca A. Cerebrospinal fluid abnormalities in 170 cases of AIDS. Arq Neuropsiquiatr 1989;47:326-31.
3. Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Bos-well RN. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988;45:954-8.
4. Pozo F, Tenório A. Detection and typing of lympgotropic her-pesviruses by multiplex polymerase chain reaction. J Virol Meth 1999;79:9-19. (Pubitemid 29182786)
5. Galen RS, Gambino SR. Beyond normality: the predictive val-ue and efficiency of medical diagnoses. New York: John Wiley & Sons, 1975, p. 237.
6. Negrini B, Kelleher KJ, Wald ER. Cerebrospinal Fluid findings in aseptic versus bacterial meningitis. Pediatrics 2000;105:316-19. (Pubitemid 30078670)
7. Posner JB, Plum F. Independence of blood and cerebrospinal fluid lactate. Arch.Neurol 1967;16:492-6.
8. Tang LM. Serial lactate determinations in tuberculous menin-gitis. Scand J Infect Dis 1988;20:81-3.
9. El Mdaghri N, Benbachir M, Tazi-Lakhsassi L, Himmich H. Significance of the determination of lactic acid in the cerebro-spinal fluid for the differential diagnosis of meningitis. Pathol Biol 1985;33:227-31. (Pubitemid 15080351)
10. Donald PR, Malan C Cerebrospinal fluid lactate and lactate dehydrogenase levels as diagnostic aids in tuberculous meningitis. S Afr Med J 1985;67:19-20. (Pubitemid 15162298)
11. Briem H. Comparison between cerebrospinal fluid concentra-tions of glucose, total protein, chloride, lactate, and total amino acids for differential diagnosis of patients with meningitis, Scand. J Infect Dis 1983;15:277-84. (Pubitemid 13019676)
12. Lindquist L, Linn T, Hansson LO, Kalin M, Axelsson G. Value of cerebrospinal fluid analysis in the diferential diagnosisd of meningitis: a study of 710 patients with suspected central sys-tem infection, Eur J Clin Microbiol Infect Dis 1988;7:374-80.
13. Cunha AB, Fatehpuria R, Eisenstein LE. Listeria monocyto-genes encephalitis mimicking Herpes simples encephalitis: the differential diagnostic importance of cerebrospinal fluid lactic acid levels. Heart Lung 2007;36:226-31. (Pubitemid 46726643)
14. Body BA, Oneson RH, Herold DA. Use of cerebrospinal fluid lactic acid concentration in diagnosis offungal meningitis, Ann Clin Lab Sci 1987;17:429-34. (Pubitemid 18047408)
15. Kleine TO, Zwerenz P, Zofel P, Zöfel P, Shiratori K. New and old diagnostic markers of meningitis in cerebrospinal fluid (CSF). Brain Research Bull 2003;61:287-97. (Pubitemid 36952475)
16. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, et al. EFNS Task Force. Guidelines on routine cere-brospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 2006;13:913-22. (Pubitemid 44284895)
17. Leib SL, Boscacci R, Gratzl O, Zimmerli W. Predictive value of cerebrospinal fluid (CSF) Lactate versus CSF/Blood glucose ratio for the diagnosis of bacterial meningitis following neu-rosurgery. Clin Infec Dis 1999;29:69-74. (Pubitemid 29336804)
18. Cabeça HL, Gomes HR, Machado LR, Livramento JA. Dosage of lactate in the cerebrospinal fluid in infectious diseases of the central nervous system. Arq Neuropsiquiatr 2001;59:843-8. (Pubitemid 33607509)
19. De Almeida SM, Faria FL, Fontes KG, Buczenko GM, Berto DB, Raboni SM, et al. Quantification of cerebrospinal fluid lactic acid in infectious and noninfectious neurological dis-eases. Clin Chem Lab Med 2009;47:755-61.
20. Donald PR, Malan C Cerebrospinal fluid lactate and lactate dehydrogenase activity in the rapid diagnosis of bacterial men-ingitis. S Afr Med J 1986;69:39-42. (Pubitemid 16165673)
21. Knight JA, Dudek SM, Haymond RE. Early (chemical) diag-nosis of bacterial meningitis-cerebrospinal fluid glucose, lac-tate, and lactate dehydrogenase compared. Clin Chem 1981;27: 1431-4. (Pubitemid 11041586)
22. Jordan GW, Statland B, Halsted C CSF lactate in diseases of the CNS. Arch Intern Med 1984;143:85-7.
23. Mandal BK, Dunbar EM, Hooper J, Parker L. How useful is cerebrospinal fluid lactate estimation in differential diagnosis of meningitis? J Infect 1983;6:231-7. (Pubitemid 13107605)
24. D'Souza E, Mandal BK, Hooper J, Parker L. Lactic acid con-centration in cerebrospinal fluid and differential diagnosis of meningitis. Lancet 1978;2:579-80.
25. Wellmer A, Prange J, Gerber J, Zysk G, Lange P, Michel U, et al. D-and L-lactate in rabbit and human bacterial meningitis. Scand J Infect Dis 2001;33:909-13. (Pubitemid 34083323)
26. Kölmel HW, von Maravic M. Correlation of lactic acid level, cell count and cytology in cerebrospinal fluid of patients with bacterial and non-bacterial meningitis. Acta Neurol Scand 1988; 78:6-9.
27. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004;558:5-30. (Pubitemid 39077388)
28. Ponka A, Ojala K, Teppo AM, Weber TH. The differential diag-nosis of bacterial and aseptic meningitis using cerebrospinal fluid laboratory tests. Infection 1983;11:129-31. (Pubitemid 13060752)
29. Cunha BA. The usefulness of CSF lactic acid levels in central Nervous System infections with decreased CSF glucose. Clin Infect Dis 2004;38:1260-1. (Pubitemid 40169338)
30. Fishman RA. Cerebrospinal Fluid in Diseases of the Nervous System. Philadelphia: Saunders, 1992, p. 431.
31. Brook I. The importance of lactic acid in body fluids in the detection of of bacterial infections. Rev Infect Dis 1981;3: 470-8.
32. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84. (Pubitemid 39458512)
33. Wong GK, Poon WS, Ip M. Use of ventricular cerebrospinal fluid lactate measurement to diagnose cerebrospinal fluid infec-tion in patients with intraventricular haemorrhage. J Clin Neu-rosc 2008;15:654-5.
34. Weyne J, van Leuven F Lactic acid in the brain and cerebro-spinal fluid in different conditions of hyperlactacidemia. Arch Int Physiol Biochim 1973;81:925-30.
35. Berger JR, Moskowitz L, Fischl M, Kelley RE. Neurologic disease as the presenting manifestation of acquired immuno-deficiency syndrome. Aids and Neurologic Disorders 1987;80: 683-5.
36. American academy of neurology Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 1998;50:21-6.
37. Resnick L, DiMarzo-Veronese F, Schupbach, Tourtellotte WW, HO DD, Müller F, et al. Intra-blood-brain-barrier synthesis of HTLV-III specific IgG in patients with neurologic symptons associated with AIDS or AIDS-related complex. N Engl J Med 1985;313:1498-504. (Pubitemid 16182478)
38. Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood brain barrier by HIV. Neurology 1988;38: 9-14. (Pubitemid 18028082)
39. Garlipp CR, Rossi CL, Bottini PV. Cerebrospinal fluid profiles in acquired immunodeficiency syndrome with and without neurocryptococcosis. Rev Inst Med Trop Sao Paulo 1997;39: 323-5. (Pubitemid 128750668)
40. Dal Pan GJ, McArthur JC Neuroepidemiology of HIV infection. Neuroepidemiology 1996;14:359-82. (Pubitemid 26157428)